Loading clinical trials...

Alexis Retractor in Total Hip Arthroplasty | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

Alexis Retractor in Total Hip Arthroplasty

Wound Healing Outcomes With and Without the Alexis Wound Retractor in Direct Anterior Approach Total Hip Arthroplasty

NCT07237737•University of Miami

Summary

To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients undergoing primary unilateral longitudinal direct anterior approach total hip arthroplasty
•Patients undergoing primary total hip arthroplasty

Exclusion Criteria

•Patients with history of prior open surgery on the affected hip
•Patients with history of prior total hip arthroplasty on the contralateral hip
•Patients with allergies or absolute contraindication to standardized drugs administered within the University of Miami protocol for total hip replacement

Locations (1)

University of Miami

Miami, Florida, United States

Key Dates

Start Date

December 1, 2026

Primary Completion Date

January 1, 2028

Completion Date

January 1, 2028

Last Updated

February 5, 2026

Enrollment

202

ESTIMATED participants

Conditions

Hip OsteoarthritisHip Arthritis

Interventions

Alexis wound retractor

DEVICE

Standard wound retractor

DEVICE

Contacts

Natalia Cruz, MD

CONTACT

305-689-5195 nxc971@miami.edu

General vs Spinal in Total Joint Arthroplasty (TJA)

NCT06747494

Knee OsteoarthritisHip Osteoarthritis

View study

RECRUITINGNA

PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults

NCT07327931

Hip OsteoarthritisHip Pain Chronic

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 5, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Alexis Retractor in Total Hip Arthroplasty

Inclusion Criteria

Exclusion Criteria

General vs Spinal in Total Joint Arthroplasty (TJA)

PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults

PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery

Effectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery.

Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty